08/14/2025
8:36 PM | Alto Neuroscience (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
4:21 PM | Alto Neuroscience (Issuer)
Sanchez Ramiro (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2025
4:22 PM | Alto Neuroscience (Issuer)
Sanchez Ramiro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
6:02 PM | Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/08/2025
4:20 PM | Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
4:21 PM | Alto Neuroscience (Issuer)
Etkin Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
4:22 PM | Alto Neuroscience (Issuer)
Savitz Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
4:22 PM | Alto Neuroscience (Issuer)
Hanley Jr. Michael Conick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
4:18 PM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
6:40 AM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
5:34 AM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ANRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
2:19 PM | Alto Neuroscience (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SCHEDULE 13G | |
05/15/2025
2:05 PM | Alto Neuroscience (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
04/01/2025
3:25 PM | Alto Neuroscience (Filer)
| Form ARS | |
03/20/2025
4:15 PM | Alto Neuroscience (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:32 PM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
3:36 PM | Alto Neuroscience (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:26 PM | Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
7:16 AM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
11:15 PM | Alto Neuroscience (Filer)
| Form EFFECT | |
02/03/2025
3:39 PM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:07 PM | Alto Neuroscience (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/16/2025
6:00 AM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:46 PM | Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:00 AM | Alto Neuroscience (Subject)
Etkin Amit (Filed by)
| Form SC 13G | |
10/22/2024
3:35 PM | Alto Neuroscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
MarketBeat All Access